I.N. BOKARYOV, L.V. POPOVA

Sechenov First Moscow State Medical University, 8 Trubetskaya St., building 2, Moscow, Russian Federation 119991

Bokaryov I.N. — D. Med. Sc., Head of the Laboratory for Thrombosis, Thrombophilia and Haemostasis Pathology, Professor of the Department of Hospital Therapy № 1, tel. (495) 471-33-59, e-mail: bokarevin@yandex.ru

Popova L.V. — Cand. Med. Sc., Associate Professor of the Department of Hospital Therapy № 1, tel. (495) 471-27-20, e-mail: mila_foka@mail.ru

Formation of thrombus in arteries, veins, heart cavities and thromboembolism in different organs causes myocardial infarction, stroke, and pulmonary embolism. Thrombus and thromboembolism are the cause of death of almost 25 mln people a year, while a lot more become invalids. Proper and due prophylactic measures can prevent unexpected death, increase life duration, improve its quality and decrease the society’s economic burden for the treatment and rehabilitation.

Key words: arterial thrombosis, venous thrombosis, thrombosis prevention.

REFERENCES

1. Hacke W. Stroke: A Disease, that has become treatable. 1998.

2. Hirsh J. Guidelines for Antitrombotic Therapy. Eighth Edition. BC Decker Inc, 2008.

3. Moreno P. Pathohosiology of atherothrombosis. In atherothrombosis: The global approach for a Global Disease. Hightlights monograph from an international expect meeting on atherothrombosis. 1998, January 26-27, Phenix. Pp. 1-4.

4. Rosamond W. et al. Heart disease and stroke statistics — 2008 update. A report from the American heart association statistics committee and stroke statistics subcommittee, 2008. P. 146.

5. MacMahon S., Peto R., Cutler J. et al. Blood pressure, stroke, and coronary heart disease. Part 1. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet, 1990, vol. 335 (8692), pp. 765-774.

6. Suslina Z.A., Tanashyan M.M. Antitromboticheskaya terapiya v angionevrologii [Antithrombotic therapy in angioneurology]. Moscow: Meditsinskaya kniga, 2004. 109 p.

7. Canon C. Contemporary diagnosis and management of the acute coronary syndrome. Published by handbooks in Health Care Co. New York, 2007.

8. Graham I. Cardiovascular disease prevention in clinical practice. 2007. ESC guidelines desk reference. ESC committee for practice guidelines. To improve the quality of clinical practice and patient care in Europe. Cardiovascular medicine. Compendium of abridged ESC guidelines, 2008, pp. 1-15.

9. Patrono C., Bachman F., Baigent C., Bode C., De Caterina R., Charbonnier B., Fitzgerald D., Hirsh J., husten S., Kvasnicka J., Montalescot G., Rodriguez L.A.G., Verheugt F., Vermylen J., Wallentin L. Expert consensus on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology. European heart journal, 25, 2004, pp. 166-181.

10. Heit J.A., Thrombophillia: common questions on laboratory assessment and management. Hematology. 2007. American Society of Hematology Education program Bock, 2007, pp. 127-35.

11. Torbicki A. The Task Force on acute Pulmonary embolism of the European Society of Cardiology , 2008. ESC guidelines desk reference. ESC committee for practice guidelines. To improve the quality of clinical practice and patient care in Europe. Cardiovascular medicine. Compendium of abridged ESC guidelines, 2008, pp. 301-13.

12. Rosendal F.R., van Hylckama V., Lieg A. et al. Estrogens, progesterone and thrombosis. Thrombosis and Haemostasis, 2003, vol. 1 (7), pp. 1321-80.

13. Ryden L., Fuster V. Artrial fibrillation 2006. ESC guidelines desk reference. ESC committee for practice guidelines. To improve the quality of clinical practice and patient care in Europe. Cardiovascular medicine. Compendium of abridged ESC guidelines, 2008, pp. 237-257.